In a first-of-its-kind announcement, the Obesity Surgery Conference revealed groundbreaking news: Type 2 Diabetes is now classified as a surgical disease.

The statement was made by top experts in various medical fields, all assembled for what has quickly become an annual event.

Conference Panel

The conference’s panel of experts included a cardiology professor, an endocrinology professor, a bariatric surgeon, and a weight management specialist.

The group came together to share their research and ideas on how to effectively treat Type 2 Diabetes.

The Surgery Process

According to the panel, surgery is the most effective way to reverse Type 2 Diabetes. The surgery process is relatively simple and involves creating a small pouch in the stomach to limit food intake.

The procedure is known as Roux-en-Y gastric bypass surgery.

The panel emphasized the importance of the procedure being performed by a qualified bariatric surgeon.

They also noted that the procedure is not suitable for all patients with Type 2 Diabetes, and that careful consideration and personalized medical advice should be sought before deciding on the surgery.

Statistics Reveal Positive Outcomes

The panel presented the results of several studies showing the positive outcomes of patients who had undergone the Roux-en-Y gastric bypass surgery.

A study in The New England Journal of Medicine showed that 95% of patients who had the surgery went into remission from Type 2 Diabetes. This was compared to only 5% of patients who received standard medical treatment.

The panel also shared another study which followed patients for five years after their surgery. The study revealed that 75% of patients were still in remission from Type 2 Diabetes five years later.

The long-term health benefits for these patients who have the surgery are promising.

Bariatric Surgery’s Effect on the Body

The Roux-en-Y gastric bypass surgery not only helps to reduce food intake, but it also regulates hormones in the body that are related to diabetes. The surgery is known to reduce inflammatory markers, which are often associated with Type 2 Diabetes.

Patients who have the surgery also show a decrease in cholesterol and blood pressure levels.

Conclusion

The Obesity Surgery Conference’s announcement marks a significant shift in the medical community’s approach to treating Type 2 Diabetes.

The new classification as a surgical disease emphasizes the benefits of Roux-en-Y gastric bypass surgery, which has been shown to be effective in putting patients into remission from the disease. The positive outcomes of the surgery continue to be studied and provide hope for those looking to improve their health and reverse their Type 2 Diabetes.